Pharmaceutical Excipients Market by Functionality, & Products - 2019

MarketsandMarkets Presents

Pharmaceutical Excipients Market by Functionality, & Products - 2019

http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html

The "Pharmaceutical Excipients Market by Products (Organic chemicals, Inorganic Chemicals), by Functionality (Fillers, Binders, Lubricants, Preservatives), by Route of Administration (Oral, Topical, Parenteral, Others)] - Global Forecast to 2019�analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.

Browse 199 market data tables and 41 figures spread through 270 pages and in-depth TOC http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market956.html Early buyers will receive 10% customization in this report The pharmaceutical excipients market was valued at $5,760.0 million in 2013 and is expected to grow at a healthy CAGR of 6.7% from 2014 to 2019.

http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html

The global pharmaceutical excipients market is segmented by product, functionality, route of administration, and geography. By product, the pharmaceutical excipients market is broadly classified into organic chemicals, and inorganic chemicals. The organic chemicals market is further sub-segmented into carbohydrates, proteins, oleochemicals and petrochemicals, and proteins. The inorganic chemicals market covers calcium products, halites, and metal oxides.

By functionality, the pharmaceutical excipients market is classified into fillers and diluents, binders, suspension and viscosity agents, coatings, flavoring agents, disintegrants, colorants, lubricants and glidants, preservatives, and other applications.

Ask for PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=956

http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html

The market is mainly driven by the increasing demand for functional excipients from the pharmaceutical industry. The rapid increase in the generics market due to patent expiration of many blockbuster drugs is expected to drive the sales of excipients in the forecast period.

However, increasing quality compliance and regulatory requirements for excipient manufacturers in order to ensure more transparency in supply chain may inhibit the growth of the market to a certain extent. Restricted number of the U.S. FDA approved manufacturing sites due to regulatory restrictions may also inhibit the growth of this market.

Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=956

http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html

North America is a major market for global pharmaceutical excipients which occupied a major share in this market, closely followed by Europe. Growth in investments on novel drug, and continuous efforts of pharmaceutical companies to offer superior-quality products are factors that have led to the large market shares of the North American and European pharmaceutical excipients markets.

The major players in the pharmaceutical excipients market are Ashland Inc. (U.S.), BASF SE (Garmany), The Dow Chemical Company (U.S.), Roquette (France), Colorcon, Inc. (U.S.), Avantor Performance Materials, Inc. (U.S.), FMC Corporation (U.S.), Evonik Industries (Germany), and Lubrizol Corporation (U.S.).

Buy Now: http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=956

http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html

About MarketsandMarkets MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html

Contact Us Mr. Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252 Tel: +1-888-6006-441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets